Equine Fluid Therapy Market

By Route Of Administration;

Intravenous and Enteral

By Fluid Type;

Crystalloids, Colloids and Combination

By End User;

Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn432789504 Published Date: August, 2025

Equine Fluid Therapy Market Overview

Equine Fluid Therapy Market (USD Million)

Equine Fluid Therapy Market was valued at USD 160.53 million in the year 2024. The size of this market is expected to increase to USD 225.89 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.


Equine Fluid Therapy Market

*Market size in USD million

CAGR 5.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.0 %
Market Size (2024)USD 160.53 Million
Market Size (2031)USD 225.89 Million
Market ConcentrationMedium
Report Pages340
160.53
2024
225.89
2031

Major Players

  • MAI Animal Health
  • Dechra Pharmaceuticals PLC
  • Zoetis Services LLC
  • Merck Animal Health
  • Abbott Laboratories
  • Luitpold Pharmaceuticals, Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Equine Fluid Therapy Market

Fragmented - Highly competitive market without dominant players


The Equine Fluid Therapy Market is expanding rapidly, fueled by increased focus on equine well-being and clinical outcomes. Used to treat conditions like dehydration, electrolyte disturbances, and systemic infections, fluid therapy plays a vital role in horse care. With over 40% of equine veterinarians utilizing fluid therapy for medical intervention, the market continues to grow steadily.

Rising Incidence of Equine Medical Conditions
A notable increase in chronic and acute conditions such as colic and kidney failure is driving the usage of intravenous and oral fluid solutions. Fluid therapy is now part of 35% of treatment regimens, making it a cornerstone of modern veterinary protocols. This heightened medical need is pushing demand for more specialized and reliable delivery solutions.

Technology Enhancing Treatment Delivery
Breakthroughs in infusion devices and sterile fluid systems are enhancing care accuracy while reducing administration-related complications. Adoption of these improved technologies has increased efficiency by 30%, making fluid therapy safer and more accessible, especially in field conditions and mobile veterinary services.

Preventive Applications Driving Market Growth
Beyond emergency care, preventive veterinary strategies now incorporate fluid therapy for routine hydration, metabolic balance, and stress prevention. With 45% of equine consultations including preventive care, this approach is shaping a market that values consistent, proactive health management in horses.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Route Of Administration
    2. Market Snapshot, By Fluid Type
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Equine Fluid Therapy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising prevalence of equine diseases
        2. Increased awareness of animal health
        3. Advances in veterinary technology
        4. Higher adoption of fluid therapy
      2. Restraints
        1. Limited access in rural areas
        2. Shortage of skilled vets
        3. Resistance to new technologies
      3. Opportunities
        1. Growing pet insurance adoption
        2. Demand for personalized equine care
        3. Advances in diagnostic tools
        4. Partnerships in veterinary healthcare
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Equine Fluid Therapy Market, By Route Of Administration, 2021 - 2031 (USD Million)
      1. Intravenous
      2. Enteral
    2. Equine Fluid Therapy Market, By Fluid Type, 2021 - 2031 (USD Million)
      1. Crystalloids
      2. Colloids
      3. Combination
    3. Equine Fluid Therapy Market, By End User, 2021 - 2031 (USD Million)
      1. Veterinary Hospitals
      2. Veterinary Clinics
      3. Veterinary Diagnostic Centers
      4. Others
    4. Equine Fluid Therapy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. MAI Animal Health
      2. Dechra Pharmaceuticals PLC
      3. Zoetis Services LLC
      4. Merck Animal Health
      5. Abbott Laboratories
      6. Luitpold Pharmaceuticals, Inc
  7. Analyst Views
  8. Future Outlook of the Market